Pfizer

M&A daily wrap: Pfizer, Antares, Thoma Bravo, Jordan Co., Rising Stars of PE

Pfizer injects $600 million into venture capital arm to back neuroscience companies; The Jordan Co. buys logistics firm; Nominate Rising Stars of PE by June 8.

Strategic buyers Demitri Diakantonis June 6

Strategic buyers Demitri Diakantonis June 6
Opinion Why lower mid-market healthcare M&A is poised for growth

Dana Pawlicki
Co-founder Stonington Capital Advisors

PE firms raising healthcare funds and strategic buyers divesting assets are among the deal drivers in the sector.

Healthcare industry May 31

Healthcare industry May 31
P&G bets on vitamins and decongestants for growth, buys Merck's consumer health unit

The deal gives the maker of Crest toothpaste a stable of products with sales growth of 6 percent in the past two years.

Consumer goods industry April 19

Consumer goods industry April 19
Sanofi delivers deal after striking out twice

The company is buying hemophilia drugmaker Bioverativ in its largest deal in seven years.

Strategic buyers January 22

Strategic buyers January 22
Frayed gasket delaying Astra's ZS-9 shows pharma M&A perils

The drugmaaker bought ZS in 2015 and it received a factory filled with problems.

Pharmaceuticals December 6, 2017

Pharmaceuticals December 6, 2017
Gilead buys cancer treatment company Kite Pharma

Bristol-Myers, Pfizer and Jazz Pharamceuticals also acquired cancer researchers.

Pharmaceuticals August 28, 2017

Pharmaceuticals August 28, 2017